Prognosis
J&J Shot to Get EU Nod in Early March, Easing Supply Squeeze
- Bloc’s medicines regulator is said to plan March 11 opinion
- Supply surge puts onus on governments to administer vaccines
Source: Johnson & Johnson
This article is for subscribers only.
The European Union’s medicines regulator is set to recommend Johnson & Johnson’s coronavirus vaccine early next month, bolstering supplies even as governments struggle to get shots into people’s arms.
The European Medicines Agency’s nod is expected on March 11, an EU official said on condition of anonymity. It would clear the way for market authorization of a fourth Covid-19 vaccine, alongside those from Moderna Inc., AstraZeneca Plc and a partnership of Pfizer Inc. and BioNTech SE.